Chemoinformaics analysis of (1S,2S,4R)-1,3,3-TRIMETHYLBICYCLO[2.2.1]HEPTAN-2-OL
| Molecular Weight | 154.253 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 7 |
| Exact Molecular Weight | 154.136 | nRing | 2 |
| Solubility: LogS | 0.802 | nHRing | 0 |
| Solubility: LogP | 0.571 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 29.5043 |
| nHD | 1 | BPOL | 18.0577 |
| QED | 0.703 |
| Synth | 1.784 |
| Natural Product Likeliness | -1.91 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.132 |
| MDCK | 0.000022 |
| BBB | 0.976 |
| PPB | 0.223178 |
| VDSS | 1.389 |
| FU | 0.712745 |
| CYP1A2-inh | 0.444 |
| CYP1A2-sub | 0.753 |
| CYP2c19-inh | 0.131 |
| CYP2c19-sub | 0.184 |
| CYP2c9-inh | 0.022 |
| CYP2c9-sub | 0.215 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.223 |
| CYP3a4-inh | 0.05 |
| CYP3a4-sub | 0.126 |
| CL | 5.753 |
| T12 | 0.722 |
| hERG | 0.052 |
| Ames | 0.007 |
| ROA | 0.46 |
| SkinSen | 0.718 |
| Carcinogencity | 0.207 |
| EI | 0.927 |
| Respiratory | 0.764 |
| NR-Aromatase | 0.02 |
| Antiviral | No |
| Prediction | 0.934817 |